Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Healthy: early-phase trial registry
225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2 of 28,963 conditions by registered trial count.
1,096 US clinical trials · 225 currently recruiting · #2 of 28,963 conditions by registered trial count
Healthy: 1,096 US clinical trials tracked, 225 recruiting.
Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.
Open enrollment, early-phase tilt
Healthy has 1,096 registered US clinical trials, 225 of them open to new participants right now, about 21% of the total.
- 225
- recruiting participants now
- 21%
- of trials open to enrollment
- 43
- in Phase 3-4 (later-stage)
- 55
- top sponsor: Eli Lilly and Company
Corpus placement: #2 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Healthy is recruiting below its size-band peers.
225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Healthy trials is spread across many organizations.
Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.
-
Most Healthy trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.
-
Healthy research is mostly interventional.
905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
1,096 total, page 10 of 22
This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants
ABL Bio
NCT05756920
Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction
Ironwood Pharmaceuticals
NCT01107236
Brain Mechanisms of Emotion and Motivation: A Mind-Body Study
Mclean Hospital
NCT01850472
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime
Wockhardt
NCT02532140
Study of the Response of Human Small Blood Vessels
National Heart, Lung, and Blood Institute (NHLBI)
NCT00001622
A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 Are Tolerated and Act in the Body in Healthy Adults
Pfizer
NCT05807490
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00812149
A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects
Pfizer
NCT01616277
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
Hanmi Pharmaceutical Company Limited
NCT01724814
Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects
Hanmi Pharmaceutical Company Limited
NCT01037543
Effects of Glutathione on Immunity in Individuals Training for a Marathon
University of North Texas, Denton, TX
NCT03725241
Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ
National Institute of Mental Health (NIMH)
NCT00088738
A Study of the Effectiveness and Efficacy of the PowerSleep Device
Philips Respironics
NCT03162328
Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sular® Extended-Release Tablets (40 mg; First Horizon) in Healthy Volunteers
Mylan Pharmaceuticals
NCT00979537
Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls
Weill Medical College of Cornell University
NCT03675282
A Study of LY3375880 in Healthy Participants
Eli Lilly and Company
NCT03343587
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
Stanford University
NCT03453801
Analysis of Heart Muscle Function Following Exercise in Patients With Heart Disease
National Heart, Lung, and Blood Institute (NHLBI)
NCT00001528
Evaluation of the Effects of a Novel Dietary Microalgae Based Ingredient on Muscle Recovery and Endurance Capacity
Microphyt
NCT05760742
Transcranial Magnetic Stimulation in Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00023062
To Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
Purdue Pharma
NCT01101178
Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria
Synlogic
NCT04629170
A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese Volunteers
Pfizer
NCT02066909
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Janssen Research & Development
NCT02034344
Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants
Rhythm Pharmaceuticals
NCT05046132
Study of the Effect of Food on the Pharmacokinetics of Mirabegron
Astellas Pharma
NCT00939757
Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects
MBX Biosciences
NCT05158335
A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)
Bausch & Lomb Incorporated
NCT00347594
A Safety, Tolerability, PD and PK Study in Healthy Adults
Trevena
NCT02211625
The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies
National Cancer Institute (NCI)
NCT00001432
An Assessment of the Glyconutrient Ambrotose™ on Immunity, Gut Health, and Safety in Men and Women
University of Memphis
NCT04386226
Evaluation of Jarro-Dophilus EPS® Probiotic Formulations
University of Florida
NCT02693314
Psychometric Testing: Cued vs. Learned Suppression
Lehigh University
NCT06074523
Capsaicin to Control Pain Following Third Molar Extraction
National Institute of Dental and Craniofacial Research (NIDCR)
NCT00088686
Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans
Sundeep Khosla, M.D.
NCT04313634
Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function
Gilead Sciences
NCT05765344
A Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Vaccinations of Ad26.RSV.preF One Year Apart in Adults Aged 60 Years and Older in Stable Health
Janssen Vaccines & Prevention B.V.
NCT02926430
A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects
Calico Life Sciences
NCT06310876
A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus
Janssen Research & Development
NCT02609789
Effects of CS-8080 in Healthy Volunteers
Daiichi Sankyo
NCT00613431
ANX-188 Thorough QT/QTc Study in Healthy Volunteers
Mast Therapeutics
NCT01790087
To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 Days
AstraZeneca
NCT01145768
Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg
Mylan Pharmaceuticals
NCT00649285
A Single-Dose Study of LY3471851 in Healthy Participants
Nektar Therapeutics
NCT04998487
Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods
Purdue Pharma
NCT01259102
Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease
Jeffrey Browning
NCT02690792
Fat Tissue Microperfusion to Measure Leptin Secretion and Its Relations With Fat Breakdown in Humans
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NCT00001722
Clinical Trial of Propranolol for Seasonal Affective Disorder
National Institute of Mental Health (NIMH)
NCT00016666
Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation
Masimo Corporation
NCT06148623
The Influence of Daily Intake of Whole Grain Barley or Oats on Biomarkers of Cardiovascular Disease
United States Department of Agriculture (USDA)
NCT01293604
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 518 |
| Phase 2 | 28 |
| Phase 3 | 11 |
| Phase 4 | 32 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Healthy right now
225 recruiting of 1,096 indexed (21% open).
Phase mix: 43 late (III/IV) vs 546 early (I/II) (early-phase heavy).
Top sponsor: Eli Lilly and Company (55 trials), 9 others listed. 50 shown below, recruiting first. #2 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Healthy?
PlainTrial tracks 1,096 US clinical trials for Healthy, of which 225 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Healthy?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.